The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
A Novel Pathway to the Manifestations of Metabolic Syndrome
Open accessAbstract
Pathways leading from obesity to the manifestations of metabolic syndrome involve a number of metabolic risk factors, as well as adipokines, mediators of inflammatory response, thrombogenic and thrombolytic parameters, and vascular endothelial reactivity. Increased adipose tissue mass contributes to augmented secretion of proinflammatory adipokines, particularly tumor necrosis factor‐α (TNFα), along with diminished secretion of the “protective” adiponectin. In our view, TNFα and adiponectin are antagonistic in stimulating nuclear transcription factor‐κB (NF‐κB) activation. Through this activation, TNFα induces oxidative stress, which exacerbates pathological processes leading to oxidized low‐density lipoprotein and dyslipidemia, glucose intolerance, insulin resistance, hypertension, endothelial dysfunction, and atherogenesis. NF‐κB activation further stimulates the formation of additional inflammatory cytokines, along with adhesion molecules which promote endothelial dysfunction. Elevated free fatty acid, glucose, and insulin levels enhance this NF‐κB activation and further downstream modulate specific clinical manifestations of metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041591798 · Cited by 1,985
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,659
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
Yang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,126
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Adipose tissue as an endocrine and paracrine organ
Mohamed-Ali, V, Pinkney, J., & Coppack, S. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800770 · Cited by 999
Frühbeck, G., Gómez-Ambrosi, J., Muruzábal, F. J., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 974
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis
Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209033200 · Cited by 911
Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.
Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., & Feingold, K. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118653 · Cited by 862
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue
Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055188.83694.b3 · Cited by 851
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845
Role of Adiponectin in Preventing Vascular Stenosis
Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206083200 · Cited by 811
Minireview: Adiposity, Inflammation, and Atherogenesis
Lyon, C. J., Law, R. E., & Hsueh, W. A. (2003) · Endocrinology · doi:10.1210/en.2003-0285 · Cited by 761
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Moller, D. E. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00272-1 · Cited by 718
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., & Kern, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118504 · Cited by 717
Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000018622.84402.ff · Cited by 695
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
Kissebah, A. H., Sonnenberg, G. E., Myklebust, J., Goldstein, M., Broman, K., James, R. G., Marks, J. A., Krakower, G. R., Jacob, H. J., Weber, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14478 · Cited by 638
Self-citationMechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S. E., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14955 · Cited by 621
An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls
Okamoto, Y., Arita, Y., Nishida, M., Muraguchi, M., Ouchi, N., Takahashi, M., Igura, T., Inui, Y., Kihara, S., Nakamura, T., et al. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978586 · Cited by 568
Combs, T. P., Wagner, J. A., Berger, J., Doebber, T., Wang, W.-J., Zhang, B. B., Tanen, M., Berg, A. H., O’Rahilly, S., Savage, D. B., et al. (2002) · Endocrinology · doi:10.1210/endo.143.3.8662 · Cited by 565
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214955 · Cited by 557
Nappo, F., Esposito, K., Cioffi, M., Giugliano, G., Molinari, A. M., Paolisso, G., Marfella, R., & Giugliano, D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01741-2 · Cited by 555
Decreased Plasma Adiponectin Concentrations in Women with Dyslipidemia
Matsubara, M. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2764 · Cited by 544
Lang, C. H., Dobrescu, C., & Bagby, G. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1727716 · Cited by 535
Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes
Fasshauer, M., Kralisch, S., Klier, M., Lossner, U., Bluher, M., Klein, J., & Paschke, R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00090-1 · Cited by 531
Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease
Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., & Van de Werf, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.844 · Cited by 530
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.
Collins, T. (1993) · PubMed · Cited by 524
YAMAMOTO, Y., HIROSE, H., SAITO, I., TOMITA, M., TANIYAMA, M., MATSUBARA, K., OKAZAKI, Y., ISHII, T., NISHIKAI, K., & SARUTA, T. (2002) · Clinical Science · doi:10.1042/cs1030137 · Cited by 490
Elevated plasma endothelin in patients with diabetes mellitus
Takahashi, K., Ghatei, M. A., Lam, H. C., O'Halloran, D. J., & Bloom, S. R. (1990) · Diabetologia · doi:10.1007/bf00403325 · Cited by 490
Rabinovitch, A., & Suarez-Pinzon, W. L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00492-9 · Cited by 466
Systemic Inflammation, Adipose Tissue Tumor Necrosis Factor, and Leptin Expression
Bulló, M., García‐Lorda, P., Megias, I., & Salas‐Salvadó, J. (2003) · Obesity Research · doi:10.1038/oby.2003.74 · Cited by 449
Motoshima, H., Wu, X., Sinha, M. K., Hardy, V. E., Rosato, E. L., Barbot, D. J., Rosato, F. E., & Goldstein, B. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020635 · Cited by 427
Association between adiponectin and mediators of inflammation in obese women
Engeli, S., Feldpausch, M., Gorzelniak, K., Hartwig, F., Heintze, U., Janke, J., Möhlig, M., Pfeiffer, A. F. H., Luft, F. C., & Sharma, A. M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.942 · Cited by 422
Inflammatory status and insulin resistance
Grimble, R. F. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200209000-00015 · Cited by 410
Decreased plasma adiponectin concentration in patients with essential hypertension
Adamczak, M. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03197-7 · Cited by 389
Comuzzie, A. G. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4321 · Cited by 326
Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4618 · Cited by 301
Greenberg, A. S., & McDaniel, M. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.4.x · Cited by 290
Increased β-Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin
Ma, K., Cabrero, A., Saha, P. K., Kojima, H., Li, L., Chang, B. H.-J., Paul, A., & Chan, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200362200 · Cited by 287
Kazumi, T., Kawaguchi, A., Sakai, K., Hirano, T., & Yoshino, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.971 · Cited by 275
NF-??B Activation and Inhibition: A Review
Sun, Z., & Andersson, R. (2002) · Shock · doi:10.1097/00024382-200208000-00001 · Cited by 262
Hauner, H., Petruschke, T., Russ, M., Röhrig, K., & Eckel, J. (1995) · Diabetologia · doi:10.1007/s001250050350 · Cited by 262
The role of PPARs in atherosclerosis
Duval, C., Chinetti, G., Trottein, F., Fruchart, J.-C., & Staels, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02385-7 · Cited by 246
Adiponectin: Systemic contributor to insulin sensitivity
Pajvani, U. B., & Scherer, P. E. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0065-2 · Cited by 244
Zinman, B., Hanley, A. J. G., Harris, S. B., Kwan, J., & Fantus, I. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5405 · Cited by 239
Hirose, H., Kawai, T., Yamamoto, Y., Taniyama, M., Tomita, M., Matsubara, K., Okazaki, Y., Ishii, T., Oguma, Y., Takei, I., et al. (2002) · Metabolism · doi:10.1053/meta.2002.30506 · Cited by 235
Tamakoshi, K., Yatsuya, H., Kondo, T., Hori, Y., Ishikawa, M., Zhang, H., Murata, C., Otsuka, R., Zhu, S., & Toyoshima, H. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802260 · Cited by 233
Pradhan, A. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000025636.03561.ee · Cited by 229
Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
Epinat, J.-C., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203218 · Cited by 211
Weyer, C., Yudkin, J. S., Stehouwer, C. D. A., Schalkwijk, C. G., Pratley, R. E., & Tataranni, P. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00626-8 · Cited by 211
Resistin and Adiponectin Expression in Visceral Fat of Obese Rats: Effect of Weight Loss
Milan, G., Granzotto, M., Scarda, A., Calcagno, A., Pagano, C., Federspil, G., & Vettor, R. (2002) · Obesity Research · doi:10.1038/oby.2002.149 · Cited by 199
Stephens, J. M., & Pekala, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42251-x · Cited by 197
The metabolic effects of tumor necrosis factor and other cytokines
Grunfeld, C., & Feingold, K. R. (1991) · Biotherapy · doi:10.1007/bf02172087 · Cited by 196
Kappes, A., & Löffler, G. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978684 · Cited by 193
Hernández-Rodríguez, J., Segarra, M., Vilardell, C., Sánchez, M., García-Martínez, A., Esteban, M.-J., Grau, J. M., Urbano-Márquez, A., Colomer, D., Kleinman, H. K., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066907.83923.32 · Cited by 191
The role of growth hormone/insulin-like growth factors in adipocyte differentiation
Wabitsch, M., Hauner, H., Heinze, E., & Teller, W. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90220-1 · Cited by 165
Azevedo-Martins, A. K., Lortz, S., Lenzen, S., Curi, R., Eizirik, D. L., & Tiedge, M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.93 · Cited by 165
Yokota, T., Meka, C. S. R., Medina, K. L., Igarashi, H., Comp, P. C., Takahashi, M., Nishida, M., Oritani, K., Miyagawa, J.-I., Funahashi, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14506 · Cited by 148
Sigurdardottir, V., Fagerberg, B., & Hulthe, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01054.x · Cited by 144
Chan, J., Cheung, J., Stehouwer, C. D. A., Emeis, J. J., Tong, P. C. Y., Ko, G., & Yudkin, J. S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802017 · Cited by 135
Schubert, S. Y., Neéman, I., & Resnick, N. (2002) · The FASEB Journal · doi:10.1096/fj.02-0147fje · Cited by 132
The acute phase protein response in patients receiving subcutaneous IL-6
Banks, R. E., Forbes, M. A., Storr, M., Higginson, J., Thompson, D., Raynes, J. G., Illingworth, J. M., Perren, T. J., Selby, P. J., & Whicher, J. T. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06659.x · Cited by 130
Katsuki, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.859 · Cited by 129
Yokota, T., Meka, C. S. R., Medina, K. L., Igarashi, H., Comp, P. C., Takahashi, M., Nishida, M., Oritani, K., Miyagawa, J., Funahashi, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214506 · Cited by 124
de Nigris, F., Lerman, L. O., Williams‐Ignarro, S., Sica, G., Lerman, A., Palinski, W., Ignarro, L. J., & Claudio Napoli, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237367100 · Cited by 111
Parissis, J., Korovesis, S., Giazitzoglou, E., Kalivas, P., & Katritsis, D. G. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00021-9 · Cited by 101
Zinman, B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.272 · Cited by 99
Kondo, A., Muranaka, Y., Ohta, I., Notsu, K., Manabe, M., Kotani, K., Saito, K., Maekawa, M., & Kanno, T. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.5.893 · Cited by 98
Endothelial function in the post-prandial state
de Koning, E. J. P., & Rabelink, T. J. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00008-3 · Cited by 90
NF- activation in endothelial cells treated with oxidized high-density lipoprotein
Matsunaga, T., Hokari, S., Koyama, I., Harada, T., & Komoda, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00308-5 · Cited by 86
Rajala, U., Laakso, M., Päivänsalo, M. J., Pelkonen, O., Suramo, I., & Keinanen-Kiukaanniemi, S. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020703 · Cited by 76
Kras, K. M., Hausman, D. B., & Martin, R. J. (2000) · Obesity Research · doi:10.1038/oby.2000.20 · Cited by 70
Endotheliopathy Precedes Type 2 Diabetes
Tooke, J. E., & Goh, K. L. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2047 · Cited by 57
Porter, M. H., Cutchins, A. C., Fine, J. B., Bai, Y., & DiGirolamo, M. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.121552 · Cited by 54
Kowalska, I., Strączkowski, M., Szelachowska, M., Kinalska, I., Prokop, J., Bachórzewska-Gajewska, H., & St[ecedil]pien, A. (2002) · Metabolism · doi:10.1053/meta.2002.32802 · Cited by 49
Chen, N.-G., Azhar, S., Abbasi, F., Carantoni, M., & Reaven, G. M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00460-8 · Cited by 46
Bolaffi, J. L., Rodd, G. G., Wang, J., et al. (1994) · Endocrinology · doi:10.1210/endo.134.2.7507826 · Cited by 35
Esposito, K., Nicoletti, G., & Giugliano, D. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345092 · Cited by 35
Interferon-γ: pleiotropic effects on a rat pancreatic beta cell line
Campbell, I. L., Oxbrow, L., & Harrison, L. C. (1987) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(87)90109-2 · Cited by 22
Schneider, M. P., Delles, C., Fleischmann, E. H., Schmidt, B. M. W., John, S., & Schmieder, R. E. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03255-1 · Cited by 10
Cited by
(1998) · PubMed · Cited by 2,737
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome
Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Collier, G., Walder, K., & Segal, D. (2007) · Endocrinology · doi:10.1210/en.2007-0175 · Cited by 858
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Effects of dietary fibers on disturbances clustered in the metabolic syndrome
Galisteo, M., Duarte, J., & Zarzuelo, A. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.02.009 · Cited by 477
Metadata
- Authors
- Sonnenberg, G. E., Krakower, G. R., & Kissebah, A. H.
- Venue
- Obesity Research
- Publisher
- Wiley
- Published
- 2004-02
- Volume
- 12
- Issue
- 2
- Pages
- 180-186
- ISSN
- 1071-7323 (ISSN-L)
- 1550-8528
- OpenAlex
- W2065182009
- Cited by
- 257
- References
- 104
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.